Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial
about
Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesionsWidespread use of gastric acid inhibitors in infants: Are they needed? Are they safe?Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies.Qualitative analysis of anatomopathological changes of gastric mucosa due to long term therapy with proton pump inhibitors: experimental studies x clinical studies.Pharmacokinetic evaluation of esomeprazole for the treatment of gastroesophageal reflux disease.Is antisecretory therapy after pancreatoduodenectomy necessary? Meta-analysis and contemporary practices of pancreatic surgeons.Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology.Safety of proton pump inhibitors and risk of gastric cancers: review of literature and pathophysiological mechanisms.Systematic review with meta-analysis: fundic gland polyps and proton pump inhibitors.Gastric neuroendocrine neoplasms and proton pump inhibitors: fact or coincidence?Proton-pump inhibitors: understanding the complications and risks.Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppressionLong-term follow up in patients with gastroesophageal reflux disease with specific emphasis on reflux symptoms, use of anti-reflux medication and anti-reflux surgery outcome: a retrospective study.
P2860
Q24187480-78E6BEBF-3779-400A-AC62-55D9DD87B958Q28072141-594DB60E-4045-47F7-8191-2A14DB67570CQ30928614-A6D56A38-A2F1-4A6D-9B28-95D05B6557B2Q38186581-397B7F9C-B136-4F2B-A6BA-C883B3DCAA0AQ38229080-BF56F433-26AB-4FF7-AB30-439AF0CA3A3DQ38359397-C9D37B9B-384F-4533-8973-3533E7AD7C45Q38547653-5A0B443D-7297-466E-983C-29EF700F291CQ38631128-2338DAB0-09A1-44CD-BB13-341166851BB7Q38955844-0181B4E5-1CD1-444C-955E-B43616F24C54Q40852115-AA1822DE-4E0C-42E3-9F19-63E63827503EQ41996131-2A00DE2F-533E-402E-BD0A-A6DA070FA88EQ42371575-831CCD2F-F1C6-4837-AA4B-EE4FF642B660Q46610233-0F0BE569-ED1F-4E5F-927B-E646701ED2A4
P2860
Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial
description
im September 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 23 September 2012
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2012
@uk
name
Gastric exocrine and endocrine ...... r follow-up in the LOTUS trial
@en
Gastric exocrine and endocrine ...... r follow-up in the LOTUS trial
@nl
type
label
Gastric exocrine and endocrine ...... r follow-up in the LOTUS trial
@en
Gastric exocrine and endocrine ...... r follow-up in the LOTUS trial
@nl
prefLabel
Gastric exocrine and endocrine ...... r follow-up in the LOTUS trial
@en
Gastric exocrine and endocrine ...... r follow-up in the LOTUS trial
@nl
P2093
P2860
P356
P1476
Gastric exocrine and endocrine ...... r follow-up in the LOTUS trial
@en
P2093
G Långström
J Hatlebakk
J-P Galmiche
LOTUS trial collaborators
S E Attwood
P2860
P304
P356
10.1111/APT.12052
P407
P577
2012-09-23T00:00:00Z